PTCT - PTC Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTCT is currently covered by 14 analysts with an average price target of $82.38. This is a potential upside of $14.89 (22.06%) from yesterday's end of day stock price of $67.49.

PTC Therapeutics's activity chart (see below) currently has 290 price targets and 249 ratings on display. The stock rating distribution of PTCT is 76.6% BUY, 17.02% HOLD and 6.38% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.75% with an average time for these price targets to be met of 298.92 days.

Highest price target for PTCT is $118, Lowest price target is $42, average price target is $64.92.

Most recent stock forecast was given by TIAGO FAUTH from WELLS FARGO on 19-Oct-2025. First documented stock forecast 21-Jul-2014.

Currently out of the existing stock ratings of PTCT, 36 are a BUY (76.6%), 8 are a HOLD (17.02%), 3 are a SELL (6.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$73

$6.6 (9.94%)

$73

10 days ago
(19-Oct-2025)

1/5 (20%)

$4.64 (6.79%)

323

Buy

$118

$51.6 (77.71%)

$120

1 months 27 days ago
(02-Sep-2025)

11/19 (57.89%)

$62.45 (112.42%)

416

Buy

$71

$4.6 (6.93%)

$70

2 months 10 days ago
(19-Aug-2025)

9/12 (75%)

$22.15 (45.34%)

185

Buy

$76

$9.6 (14.46%)

$84

2 months 10 days ago
(19-Aug-2025)

10/13 (76.92%)

$27.15 (55.58%)

37

Hold

$46

$-20.4 (-30.72%)

$42

3 months 1 days ago
(28-Jul-2025)

13/16 (81.25%)

$-3.29 (-6.67%)

259

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PTCT (PTC Therapeutics) average time for price targets to be met?

On average it took 298.92 days on average for the stock forecasts to be realized with a an average price target met ratio 66.75

Which analyst has the current highest performing score on PTCT (PTC Therapeutics) with a proven track record?

KRISTEN KLUSKA

Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?

Kristen Kluska works at CANTOR FITZGERALD and has 2 price targets and 3 ratings on PTCT

Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?

Kristen Kluska with highest potential upside - $51.6

Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?

Heather Behanna with lowest potential downside - -$54.4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?